USPTO serial 88373158
COMMAND-LINE ACCESS TO LIFE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 16, 2021
- Examiner
- CALLOWAY, CHRISTINA DENISE
- Law office
- TMO LAW OFFICE 122
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with COMMAND-LINE ACCESS TO LIFE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Katrina G. Hull
Katrina G. Hull Markery Law LLCP.O. Box 84150Gatihersburg, MD 20883UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research purposes; Stem cells for scientific purposes; Stem cells other than for medical or veterinary purposes; Provision of skeletal myocytes for research purposes; Provision of cortical neurons for research purposes; Biological human tissue for research and scientific purposes; Biological tissue cultures other than for medical or veterinary purposes; Cultures of cell media; Chemical reagents for use in biotechnology, other than for medical or veterinary use; Nutritive agents for processing living cells; Semi-processed natural proteins for manufacturing food; Proteins for use in the manufacture of food products; Proteins for use in recombinant DNA technology | ACTIVE | — |
| 005 | Pharmaceuticals in the nature of cell therapeutics; Genetically and otherwise modified cells for medical or clinical use; Cells which are propagated, cultivated and expanded in bioreactors for medical or clinical use; Cells for the purpose of tissue regeneration for medical or clinical use; Living cells for medical use; Cells for medical use; Diagnostic preparations for medical and veterinary purposes; Cell preparations for drug screening; Cell preparations for genetic testing, screening; Stem cells for medical purposes; Stem cells for veterinary purposes; Cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical, medical research and diagnostic or clinical use; Tissue culture media, growth factors in the nature of cell growth, cell growth media, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells; Cell separation reagents for medical or clinical use; Dietary supplements; Protein supplements; nutrition supplements | ACTIVE | — |
| 009 | Downloadable computer software and computer hardware for the separation of biological and non-biological materials; Bioreactors for biomanufacturing; Bioreactors for research use; Bioreactor for cell culturing; Bioreactors for laboratory use; Downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; Smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; Electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; magnetic cell separation equipment, namely, apparatus for the separation of cell populations for medical or clinical use | ACTIVE | — |
| 029 | Meat; Meat substitutes; Tissue engineered meat; Synthetic meat; Cultured meat; Laboratory-grown meat; Fish, not live | ACTIVE | — |
| 042 | Biotechnology research; Biotechnology testing; Stem cell research; Synthetic biology services, namely, biological research; Stem cell biology services, namely, biological research; Scientific services relating to the isolation and cultivation of human tissues and cells; Research and development in the field of microorganisms and cells; Research and development in relation to genetic testing, screening; Research and development in relation to drug screening; Cell separation technology services; Cell separation research services; Consultancy relating to biotechnology; Scientific and research consultancy relating to drug screening; Scientific and research consultancy relating to genetic screening; Scientific and research consultancy relating to cell therapy; Laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and biomanufacturing; Research on food; Research and development in the field of animal cells cultivated within bioreactors; Research in the reduction of carbon emissions; Providing temporary use of non-downloadable, cloud-based, computer-aided manufacturing software for the separation of biological and non-biological materials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Elpis Biomed Ltd
- Other trademarks owned by Elpis Biomed Ltd
- Other trademarks owned by Elpis Biomed Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 029
- Other trademarks in Class 042
- Similar marks named COMMAND-LINE ACCESS TO LIFE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 24, 2023 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Dec 17, 2022 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Dec 14, 2022 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Jun 30, 2022 | PRAM | POST REGISTRATION ACTION MAILED - SEC. 7 | — |
| Jun 23, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 1, 2022 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Nov 16, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 31, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 31, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 11, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 28, 2021 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Mar 9, 2021 | ATRQ | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | — |
| Mar 9, 2021 | PCBG | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | — |
| Mar 5, 2021 | APET | ASSIGNED TO PETITION STAFF | — |
| Feb 12, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 11, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 11, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 28, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 28, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 21, 2020 | TPAD | TEAS PETITION TO AMEND BASIS RECEIVED | — |
| Jul 28, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 2, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 2, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 13, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 29, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 23, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 10, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 10, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 10, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 8, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 8, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 8, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 19, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 19, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 24, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 24, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 26, 2019 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 26, 2019 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 26, 2019 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 17, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 9, 2019 | NWAP | NEW APPLICATION ENTERED | — |